Finckenstein Friedrich Graf Iovance Biotherapeutics, Inc. (IOVA) insider trading activity

Finckenstein Friedrich Graf is Chief Medical Officer of IOVANCE BIOTHERAPEUTICS, INC.. Currently has a direct ownership of 60,727 shares of IOVA, which is worth approximately $550,793. The most recent transaction as insider was on Oct 14, 2024, when has been sold 1,428 shares (Common Stock) at a price of $9.77 per share, resulting in proceeds of $13,951. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 60.7K

2.33% 3M change

87.6% 12M change

Total Value Held $550,793

FINCKENSTEIN FRIEDRICH GRAF Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 14 2024	SELL Payment of exercise price or tax liability	$13,951 $9.77 p/Share	1,428 Reduced 2.3%	60,727 Common Stock
Oct 14 2024	BUY Exercise of conversion of derivative security	-	2,813 Added 4.33%	62,155 Common Stock
Sep 03 2024	SELL Payment of exercise price or tax liability	$150,532 $10.85 p/Share	13,874 Reduced 18.95%	59,342 Common Stock
Sep 03 2024	BUY Exercise of conversion of derivative security	-	27,345 Added 27.74%	71,233 Common Stock
Jul 15 2024	SELL Payment of exercise price or tax liability	$12,395 $8.68 p/Share	1,428 Reduced 3.02%	45,871 Common Stock
Jul 15 2024	BUY Exercise of conversion of derivative security	-	2,813 Added 5.61%	47,299 Common Stock
Jun 03 2024	SELL Payment of exercise price or tax liability	$16,589 $8.37 p/Share	1,982 Reduced 4.27%	44,486 Common Stock
Jun 03 2024	BUY Exercise of conversion of derivative security	-	3,906 Added 7.75%	46,468 Common Stock
Apr 15 2024	SELL Payment of exercise price or tax liability	$16,967 $11.89 p/Share	1,427 Reduced 3.24%	42,562 Common Stock
Apr 15 2024	BUY Exercise of conversion of derivative security	-	2,812 Added 6.01%	43,989 Common Stock
Mar 04 2024	SELL Payment of exercise price or tax liability	$136,578 $16.96 p/Share	8,053 Reduced 16.36%	41,177 Common Stock
Mar 04 2024	BUY Exercise of conversion of derivative security	-	15,623 Added 24.09%	49,230 Common Stock
Jan 16 2024	SELL Payment of exercise price or tax liability	$13,199 $8.37 p/Share	1,577 Reduced 4.48%	33,607 Common Stock
Jan 16 2024	BUY Exercise of conversion of derivative security	-	2,813 Added 7.4%	35,184 Common Stock
Oct 16 2023	SELL Payment of exercise price or tax liability	$4,980 $3.57 p/Share	1,395 Reduced 4.13%	32,371 Common Stock
Oct 16 2023	BUY Exercise of conversion of derivative security	-	2,813 Added 7.69%	33,766 Common Stock
Jul 14 2023	SELL Payment of exercise price or tax liability	$10,825 $7.76 p/Share	1,395 Reduced 4.31%	30,953 Common Stock
Jul 14 2023	BUY Exercise of conversion of derivative security	-	2,813 Added 8.0%	32,348 Common Stock
Apr 14 2023	SELL Payment of exercise price or tax liability	$7,867 $5.64 p/Share	1,395 Reduced 4.51%	29,535 Common Stock
Apr 14 2023	BUY Exercise of conversion of derivative security	-	2,812 Added 8.33%	30,930 Common Stock
Jan 17 2023	SELL Payment of exercise price or tax liability	$30,079 $6.43 p/Share	4,678 Reduced 14.26%	28,118 Common Stock
Jan 17 2023	BUY Exercise of conversion of derivative security	-	11,248 Added 25.54%	32,796 Common Stock
Jan 03 2023	SELL Payment of exercise price or tax liability	$67,350 $6.11 p/Share	11,023 Reduced 33.84%	21,548 Common Stock
Jan 03 2023	BUY Exercise of conversion of derivative security	-	19,690 Added 37.68%	32,571 Common Stock
Jun 14 2022	SELL Payment of exercise price or tax liability	$52,634 $7.73 p/Share	6,809 Reduced 34.58%	12,881 Common Stock

FFG

Finckenstein Friedrich Graf

Chief Medical Officer

San Carlos, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IOVA shares.

Notify only if

Value

Insider Trading

Get notified when an Iovance Biotherapeutics, Inc. insider buys or sells IOVA shares.

Notify only if

Operation

Value

Type

News

Receive news related to IOVANCE BIOTHERAPEUTICS, INC.

Track Activities on IOVA

Account